What is asiatic acid and where does it come from?

Asiatic acid is a pentacyclic triterpenoid aglycone isolated from Centella asiatica (gotu kola), a medicinal herb widely distributed across tropical Asia. It is the hydrolytic product of the saponin asiaticoside and occurs in leaf tissue at approximately 1.99 mg/g dry weight, alongside related triterpenes including madecassoside, asiaticoside, and madecassic acid. The compound has been studied for its anticancer, anti-inflammatory, neuroprotective, and antifibrotic properties in preclinical models.

How does asiatic acid fight cancer?

Asiatic acid exerts anticancer effects by simultaneously suppressing two major oncogenic signaling networks: the Src/FAK/ERK pathway, which governs cell migration and invasion, and the PI3K/Akt pathway, which promotes cancer cell survival and resistance to apoptosis. By reducing phosphorylation of these kinases, asiatic acid inhibits tumor cell proliferation, blocks angiogenesis, and induces apoptotic cell death in multiple cancer cell line models. It is important to note that all current evidence is preclinical; no human clinical trials on asiatic acid as a cancer intervention have been conducted.

What is the difference between asiatic acid and asiaticoside?

Asiaticoside is a triterpenoid saponin—a glycoside form in which asiatic acid is conjugated to a sugar moiety (rhamnose and glucose residues), making it more water-soluble and less membrane-permeable. Asiatic acid is the aglycone, meaning the sugar has been cleaved, yielding a more lipophilic free acid form with potentially greater membrane penetration and direct intracellular bioactivity. Both compounds co-occur in Centella asiatica, and their pharmacological activities overlap significantly, though direct comparative bioavailability studies in humans are lacking.

Is there a recommended dose of asiatic acid for supplementation?

No clinically validated dose of isolated asiatic acid has been established, as no human pharmacokinetic or dose-finding studies have been published to date. Centella asiatica standardized extracts—which contain asiatic acid as part of a triterpene complex—are typically used at 300–680 mg/day, standardized to ≥40% total triterpenoids. Until human trials characterize bioavailability, effective concentrations, and safety thresholds for isolated asiatic acid, dosing recommendations cannot responsibly be specified.

Is asiatic acid safe to take, and does it interact with medications?

Isolated asiatic acid has no formally characterized human safety profile, though preclinical studies using Centella asiatica extracts (which contain asiatic acid) have not identified significant toxicity at studied doses. Rare case reports of hepatotoxicity associated with high-dose or prolonged Centella asiatica extract use suggest caution in individuals with liver disease or those taking hepatotoxic drugs. Theoretical drug interactions exist with kinase-inhibiting cancer therapies, PI3K/Akt-targeting agents, and hepatically metabolized medications, but these have not been formally studied; pregnant or lactating individuals should avoid supplementation pending safety data.

What does clinical research show about asiatic acid's antioxidant benefits?

Clinical and in vitro studies demonstrate that asiatic acid effectively scavenges reactive oxygen species (ROS) and elevates intracellular glutathione (GSH) levels, which are key markers of antioxidant defense. This ROS-neutralizing activity supports cellular protection against oxidative stress-related damage and may contribute to its broader anti-inflammatory and neuroprotective effects. However, most evidence comes from laboratory and animal studies, with human clinical trials remaining limited in scope.

Who would benefit most from taking asiatic acid supplements?

Asiatic acid may be most beneficial for individuals seeking antioxidant support, those with high oxidative stress, and potentially cancer patients undergoing conventional treatment—though supplementation should only occur under medical supervision in the latter case. People interested in cognitive health and skin integrity may also benefit, given centella asiatica's traditional use in these areas. Those with existing liver or kidney conditions should consult a healthcare provider before supplementing.

How does the bioavailability of asiatic acid from supplements compare to whole centella asiatica extract?

Isolated asiatic acid may have different absorption kinetics than asiatic acid consumed as part of whole centella asiatica extract, where it works synergistically with asiaticoside and other triterpenes. Standardized extracts or combined triterpene formulations may enhance bioavailability through complementary mechanisms, though direct comparative bioavailability studies in humans are limited. The presence of food and fat intake can improve absorption of this lipophilic compound regardless of source form.

Asiatic acid

Asiatic acid is a pentacyclic triterpenoid that exerts anticancer, anti-inflammatory, neuroprotective, and antifibrotic effects by modulating Src/FAK/ERK and PI3K/Akt signaling pathways, suppressing TGF-β1/SMAD2/3 cascades, and scavenging reactive oxygen species. Preclinical evidence demonstrates inhibition of tumor cell proliferation, migration, and angiogenesis, along with protection against oxidative neuronal injury and APAP-induced hepatotoxicity, though human clinical trials on isolated asiatic acid remain absent from the published literature.

Category: Compound Evidence: 1/10 Tier: Preliminary

Origin & History

Asiatic acid is a pentacyclic triterpenoid aglycone naturally occurring in Centella asiatica (gotu kola), a creeping herbaceous plant native to the wetlands of Asia, including India, Sri Lanka, China, Indonesia, and Southeast Asia. The plant thrives in tropical and subtropical climates, typically growing in moist, shaded environments along riverbanks, paddy fields, and forest margins. Asiatic acid accumulates predominantly in the leaves and aerial parts of the plant, where it exists as the aglycone form of the saponin asiaticoside, released upon hydrolysis.

Historical & Cultural Context

Centella asiatica, the botanical source of asiatic acid, has been documented in traditional Ayurvedic medicine as 'Mandukparni' and in traditional Chinese medicine as 'Ji Xue Cao' for over two millennia, where it was prescribed for wound healing, mental clarity, longevity, and as a treatment for leprosy and skin disorders. In Southeast Asian folk medicine traditions, particularly across Sri Lanka, India, Indonesia, and Thailand, fresh leaves were consumed as a vegetable, brewed as teas, or applied topically as poultices to accelerate wound closure and treat skin infections. The isolation and structural characterization of asiatic acid as a discrete triterpenoid aglycone emerged from 20th-century phytochemical research aimed at identifying the active principles underlying the empirically observed therapeutic effects of gotu kola preparations. Modern scientific interest in asiatic acid's anticancer and neuroprotective properties represents a recontextualization of its traditional anti-inflammatory and wound-healing reputation through the lens of molecular pharmacology.

Health Benefits

- **Anticancer Activity**: Asiatic acid inhibits proliferation, migration, and angiogenesis in cancer cell lines via suppression of Src/FAK/ERK phosphorylation and the PI3K/Akt survival pathway, reducing tumor cell viability without equivalent toxicity to normal cells.
- **Antioxidant Protection**: The compound scavenges reactive oxygen species (ROS), elevates intracellular glutathione (GSH) levels, and reduces malondialdehyde (MDA), a key lipid peroxidation biomarker, thereby protecting cells from oxidative damage.
- **Neuroprotection**: In amyloid-beta (Aβ)-induced oxidative stress models using PC12 and IMR32 neuronal cells, asiatic acid and related triterpenes from Centella asiatica reverse GSH depletion and suppress neuroinflammatory signaling, suggesting utility in neurodegenerative disease contexts.
- **Anti-inflammatory Effects**: Asiatic acid modulates ROS, GSH, and MDA in myoblast models and downregulates pro-inflammatory mediators, contributing to the attenuation of chronic low-grade inflammation relevant to metabolic and musculoskeletal disorders.
- **Antifibrotic and Pulmonary Protection**: By blocking TGF-β1/SMAD2/3 signaling in pulmonary arterial smooth muscle cells (PASMCs), asiatic acid inhibits pathological cell proliferation and migration while inducing apoptosis, offering a molecular basis for its use in pulmonary hypertension research.
- **Hepatoprotection**: Related triterpenes from Centella asiatica, including asiatic acid, demonstrate protective effects against acetaminophen (APAP)-induced hepatotoxicity by reversing GSH depletion, reducing MDA elevation, and suppressing hepatic inflammatory markers in preclinical models.
- **Antibacterial Activity**: Asiatic acid exhibits antimicrobial properties against both gram-positive organisms such as Enterococcus faecalis and gram-negative organisms such as Escherichia coli, suggesting a broad-spectrum bacteriostatic or bactericidal mechanism relevant to integrative infection management.

How It Works

Asiatic acid exerts its anticancer effects primarily through dual suppression of the Src/FAK/ERK and PI3K/Akt signaling axes, reducing phosphorylation of focal adhesion kinase (FAK) and extracellular signal-regulated kinase (ERK) to attenuate cell migration and angiogenic signaling, while downregulating Akt-mediated survival to promote apoptosis in malignant cells. Its antifibrotic action is mechanistically linked to blockade of TGF-β1-induced phosphorylation of SMAD2 and SMAD3 transcription factors, thereby interrupting the canonical fibrogenic cascade responsible for smooth muscle cell hyperproliferation in conditions such as pulmonary arterial hypertension. At the redox level, asiatic acid elevates glutathione (GSH) through upregulation of antioxidant enzyme activity, scavenges ROS directly, and reduces lipid peroxidation products (MDA), providing cytoprotection against oxidative and inflammatory insults. Additional molecular targets include modulation of apoptotic regulators such as Bcl-2 family proteins and caspase cascades, consistent with its antiapoptotic effects in non-malignant tissues and pro-apoptotic effects in tumor cell lines.

Scientific Research

The evidence base for asiatic acid consists almost exclusively of in vitro cell culture studies and rodent preclinical models; no registered human clinical trials specifically investigating isolated asiatic acid as an intervention have been identified in the peer-reviewed literature to date. Preclinical studies have demonstrated inhibition of cancer cell proliferation and migration in multiple cancer cell lines, reversal of Aβ-induced oxidative stress in PC12 and IMR32 neuronal cells, and attenuation of APAP-induced hepatotoxicity in rat models, with mechanistic endpoints such as GSH/MDA ratios and SMAD phosphorylation. Clinical evidence from Centella asiatica extract trials (which contain asiatic acid alongside asiaticoside and madecassoside) supports wound healing and venous insufficiency outcomes, but attribution of efficacy to asiatic acid specifically cannot be made from these multi-component extract studies. The current evidence base is classified as preliminary, warranting cautious interpretation and prospective clinical investigation before therapeutic claims can be substantiated.

Clinical Summary

No published randomized controlled trials or observational clinical studies have evaluated isolated asiatic acid supplementation in human populations, representing a significant gap in translational evidence. Centella asiatica extract trials have examined wound healing acceleration and chronic venous insufficiency with modest positive outcomes, but the phytochemical complexity of these extracts—containing asiaticoside, madecassoside, and madecassic acid alongside asiatic acid—precludes isolating asiatic acid's contribution. Preclinical rat models of exercise-induced fatigue showed that Centella asiatica extract increased glycogen storage and antioxidant enzyme activity while reducing lipid peroxidation, endpoints consistent with asiatic acid's known redox mechanisms. Clinical confidence in asiatic acid as a standalone therapeutic agent remains very low due to the complete absence of human pharmacokinetic, dose-response, or efficacy trial data.

Nutritional Profile

Asiatic acid is a pure pentacyclic triterpenoid compound (molecular formula C30H48O5, molecular weight 488.7 g/mol) and does not contribute macronutrients, vitamins, or minerals in the conventional nutritional sense. In Centella asiatica leaves, asiatic acid occurs at approximately 1.99 ± 0.09 mg/g dry weight, representing a minor fraction of the total triterpene pool (~15.36 mg/g total triterpenes), which itself constitutes roughly 8% of the herb's dry mass. The compound's lipophilic triterpenoid structure confers moderate fat solubility, which influences its absorption and distribution; bioavailability from whole plant extracts is expected to differ from that of isolated compound formulations, though human pharmacokinetic data are not established. Co-occurring phytochemicals in Centella asiatica, including madecassoside (dominant saponin), asiaticoside, and madecassic acid, likely influence the absorption and synergistic biological activity of asiatic acid in whole-plant preparations.

Preparation & Dosage

- **Traditional Aqueous/Ethanolic Extract (Centella asiatica)**: Dried aerial parts prepared as 300–680 mg standardized extract per day, typically standardized to contain ≥40% total triterpenoids (asiaticoside, asiatic acid, madecassoside, madecassic acid combined); no isolated asiatic acid dose established.
- **Ethanol Dynamic Maceration**: Aerial parts of Centella asiatica extracted with 60–80% ethanol; yields variable asiatic acid content typically in the range of 1–2 mg/g dry weight of plant material.
- **Microwave-Assisted Extraction (MAE)**: Produces leaf extracts where asiatic acid is among the dominant triterpenes; used for research-grade isolation rather than commercial supplementation.
- **Subcritical Water Extraction**: Applied to leaves, nodes, petioles, and roots; yields asiaticoside-dominant fractions with asiatic acid present; solvent-free method with pharmaceutical research applications.
- **Isolated Asiatic Acid (Research Grade)**: No clinically validated supplemental dose exists; experimental in vitro concentrations range from 10–100 µM; oral bioavailability in humans is uncharacterized.
- **Timing Note**: Traditional Centella asiatica preparations are typically consumed with food to reduce gastrointestinal discomfort; no fasting or circadian timing data exist for isolated asiatic acid.

Synergy & Pairings

Asiatic acid demonstrates potential synergy with other Centella asiatica triterpenes—particularly asiaticoside and madecassoside—whereby the saponin glycosides may enhance aqueous solubility and mucosal delivery while asiatic acid contributes direct membrane-permeant bioactivity, as reflected in the superior pharmacological outcomes reported for whole-extract preparations versus isolated fractions. In neuroprotective contexts, combination with other antioxidant compounds such as alpha-lipoic acid or curcumin may amplify GSH restoration and ROS attenuation through complementary redox mechanisms, though direct combinatorial studies on asiatic acid specifically are limited to preclinical data. For anticancer applications, preclinical rationale supports stacking asiatic acid with PI3K/Akt pathway inhibitors or anti-angiogenic agents, as its multi-node suppression of Src/FAK/ERK and PI3K/Akt may exhibit additive or synergistic growth-inhibitory effects warranting formal investigation.

Safety & Interactions

Isolated asiatic acid has no formally established safety profile in humans, as clinical pharmacokinetic or toxicology studies have not been published; preclinical rodent models of Centella asiatica extract administration have not reported significant adverse effects at tested doses, suggesting low acute toxicity. Whole-plant Centella asiatica extracts have been associated with mild hepatotoxicity at high doses or with prolonged use in rare case reports, and since asiatic acid is a constituent of these extracts, hepatic monitoring may be prudent with intensive supplementation. Potential drug interactions have not been pharmacologically characterized for asiatic acid specifically, though its inhibition of PI3K/Akt and ERK pathways raises theoretical concern for interactions with kinase-targeting oncology drugs, immunosuppressants, and hepatically metabolized compounds via CYP450 modulation. Use during pregnancy and lactation is not recommended due to absent safety data; individuals with liver disease or those taking hepatotoxic medications should exercise caution with Centella asiatica preparations containing asiatic acid.